ClinicalTrials.gg
RecruitingNCT07673575SNAG MulliganUpdated Oct 21, 2026

EFFECT OF MULLIGAN CERVICAL SUSTAINED NATURAL APOPHYSEAL GLIDE ON POSTURAL STABILITY IN PATIENTS WITH CHRONIC NECK PAIN

An interventional study of 1- The Biodex Balance System (BBS) and 2-The Numerical Pain Rating Scale (NPRS) in Chronic Neck Pain With Mobility Deficits and Chronic Neck Pain With Mobility Deficits (> 3 Months), sponsored by Menna Allah Ahmed Marei Elnaggar. Recruiting at 1 site in Egypt. Open to participants aged 20 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-10-21.

Sponsored by Menna Allah Ahmed Marei Elnaggar · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jul 2026; still recruiting 4 months later.
Updated Oct 21, 2026Now RecruitingSite recruiting status changed+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
20 Years to 45 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 93 studies in Neck Pain with a site in Egypt — 32 open to participants now, 36 under way, none of them phase 3. Neck Pain · Egypt.

Planned enrollment
49th of 72
44 · median 55
Started
2026
with 15 others
No phase
71 of 93
28 open now
Primary completion
2026-10
later than 25 of 35 live
Registered
86th of 93
by date

Among the 93 studies in Neck Pain with a site in Egypt, this one is the 49th largest by planned enrollment of the 72 interventional ones that give a count, is one of 16 that started in 2026, is one of 71 with no phase, reaches primary completion later than 25 of the 35 other live ones, and was the 86th registered.

Neck Pain

1,367 studies on the registry are indexed under Neck Pain; 301 are open to participants now.

Browse Neck Pain studies →

Open to participants now

32 of the 93 studies in Neck Pain with a site in Egypt are open now. Recruiting first, the newest first:

26 more — sign in →

All 32 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 158 Neck Pain studies recruiting now, 25 (16%) set no upper age limit and 120 (76%) stop at 75 or younger; 8 take children under 18; 27 take healthy volunteers.

This study: 20 Years to 45 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 93 studies in Neck Pain with a site in Egypt, or all of them as a file.
02

Study summary

This study seeks to address the identified research gap by objectively investigating the effect of Mulligan Cervical SNAGs on postural stability in individuals with chronic neck pain and mobility impairments. The findings aim to provide evidence-based insights into whether restoring joint mobility through this manual intervention can effectively enhance sensorimotor control and balance performance. The study aims to determine if adding SNAG to a conventional exercise program provides superior improvements in balance indices (OSI, APSI, MLSI), Pain, functional disability, Range of motion, Joint position sense, and kinesiophobia compared to exercise alone. The primary purpose of this study is to answer the following research questions:

  • Does the application of cervical SNAGs lead to a significant improvement in the postural stability of patients with chronic neck pain with mobility deficits?
  • Is there a correlation between the improvement in cervical range of motion (ROM) following SNAGs and the enhancement of postural control performance?
Read the detailed description

Chronic neck pain associated with mobility deficits is a prevalent musculoskeletal condition that extends beyond localized discomfort to involve significant sensorimotor disturbances. The cervical spine plays a pivotal role in postural control due to its high density of mechanoreceptors and its intricate integration with the vestibular and visual systems. Patients with CNP frequently exhibit impaired proprioception and increased postural sway. This leads to a higher risk of falls and functional limitations. If SNAG is proven effective, the results will help clinicians justify the inclusion of Mulligan SNAGs in rehabilitation protocols not only to restore mobility and reduce pain but also to address balance impairments and kinesiophobia in patients with chronic neck pain. From a patient perspective, these improvements may enhance functional performance, confidence during movement, and quality of life. From a socioeconomic perspective, improving functional abilities and reducing disability may decrease healthcare costs, work absenteeism, and the long-term burden associated with chronic neck pain. Scientifically, this study may contribute to the growing body of evidence regarding the sensorimotor and balance-related effects of Mulligan SNAG techniques and provide further insight into the relationship between cervical mobility, postural stability, and kinesiophobia in patients with chronic neck pain.

03

Conditions studied

  • Chronic Neck Pain With Mobility Deficits
  • Chronic Neck Pain With Mobility Deficits (> 3 Months)

Browse trials for

Keywords

  • SNAG
  • chronic neck pain with mobility deficits
  • MULLIGAN
04

Who can participate

Ages eligible
20 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • The patients will be selected according to the following criteria:

    1. Adults aged between 20 and 45 years
    2. from 18.5 - 24.99 kg/ m2.
    3. Chronic neck pain lasting ≥3 months
    4. Diagnosis of neck pain with mobility deficits, including restricted cervical ROM, and pain provoked with movement
    5. Presence of cervical hypomobility confirmed by segmental mobility assessment on clinical examination
    6. Pain intensity ≥3/10 on the numerical Pain Rating Scale
    7. Reduced cervical range of motion in at least one direction measured objectively (by digital inclinometer)
    8. Ability to stand independently without assistive devices (required for postural stability assessment)

Exclusion criteria

Exclusion Criteria:

  • The patients will be excluded if they present with:

    1. Specific causes of neck pain, such as fracture, tumor, infection, inflammatory disease, or cervical myelopathy, confirmed by X Ray and physical examination
    2. Cervical radiculopathy or neurological deficits (e.g., dermatomal sensory loss, reflex changes, or muscle weakness)
    3. History of cervical spine surgery or recent trauma (within the last 6 months)
    4. Vestibular disorders or conditions affecting balance (e.g., vertigo unrelated to cervical origin)
    5. Temporomandibular disorders, significant shoulder pathology, and shoulder surgeries that may influence cervical movement or outcomes
    6. Participation in physiotherapy or manual therapy for neck pain within the previous 3 months
    7. Pregnancy or any medical condition contraindicates manual therapy
    8. History of chronic ankle instability
    9. Any lower limb pathology affecting balance
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
44 participants (estimated)

Study arms

  • Experimental
    Group A will include 22 patients with chronic neck pain with mobility deficits

    Group A (Experimental: Mulligan cervical SNAG plus conventional physiotherapy) (Mulligan Cervical SNAG Plus Conventional Therapy) Mulligan Cervical SNAG Technique Protocol: * Patient positioning: Seated or standing, with spine in neutral or slight flexion. * Therapist hand placement: Thumb or fingers on the targeted cervical vertebra (e.g., C2-C7 or upper thoracic T1-T4). * Direction of glide: Anterior and upward glide along the plane of the facet joint, synchronized with the patient's active movement (e.g., rotation, extension) * Repetitions: 10 repetitions per session, each held for 10 seconds, with rest intervals * Session structure: SNAG mobilizations performed first, followed by conventional exercises. * Cervical spine: Targeted for joint position sense, pain, and dizziness Conventional Therapy Based on the American Physical Therapy Association (APTA) Clinical Practice Guidelines for Neck Pain with Mobility Deficits, participants in the conventional therapy

    Diagnostic Test: 1- The Biodex Balance System (BBS) · Diagnostic Test: 2-The Numerical Pain Rating Scale (NPRS) · Diagnostic Test: 3- The Neck Disability Index (Arabic version) for functional disability · Diagnostic Test: 4- Digital Inclinometer for Cervical Range of Motion · Diagnostic Test: 5- Arabic Tampa Scale of Kinesiophobia (TSK-11) · Diagnostic Test: 6- Overhead LASER pointer for Cervical proprioception · Other: Mulligan Cervical SNAG Technique Protocol · Other: Conventional therapy group

  • Other
    Group B = 22 patients with chronic neck pain with mobility deficits

    Control Group (Conventional Therapy Only) * Range of motion (ROM) exercises: Cervical flexion, extension, rotation, lateral flexion * Strengthening: Deep cervical flexors, scapular stabilizers * Stretching: Targeting neck and upper back muscles (Upper trapezius stretch - Levator scapulae stretch - Pectoralis stretch) * Patient education: Posture, ergonomics, activity modification. Protocol structure: * Exercises and manual therapy delivered in 20-30 minute sessions * No SNAG mobilizations. Treatment Frequency and Session Duration Typical regimen: * 2 sessions/week for eight weeks. * 16 sessions total. * 4-week follow-up. * Session duration: 20-30 minutes.

    Diagnostic Test: 1- The Biodex Balance System (BBS) · Diagnostic Test: 2-The Numerical Pain Rating Scale (NPRS) · Diagnostic Test: 3- The Neck Disability Index (Arabic version) for functional disability · Diagnostic Test: 4- Digital Inclinometer for Cervical Range of Motion · Diagnostic Test: 5- Arabic Tampa Scale of Kinesiophobia (TSK-11) · Diagnostic Test: 6- Overhead LASER pointer for Cervical proprioception · Other: Conventional therapy group

Interventions

  • Diagnostic test1- The Biodex Balance System (BBS)

    The Biodex Balance System SD Model 950-441(Biodex Medical Systems, Inc.) is a multi-dimensional (static and dynamic) postural control assessment and training system. It provides objective, valid, and reliable measures of a patient's ability to balance on stable and unstable surfaces. It measures the overall Stability Index (OSI), anterior/posterior stability index (APSI), and medial/lateral stability index (MLSI). Its intraclass correlation coefficient (ICC) reliability is R = 0.92 (OSI), R = 0.89 (APSI), and R = 0.93 (MLSI). Chronic neck pain subjects have demonstrated significantly worse Biodex balance performance across OSI, APSI, and MLSI

  • Diagnostic test2-The Numerical Pain Rating Scale (NPRS)

    The Numerical Pain Rating Scale (NPRS) is a unidimensional measure of pain intensity that serves as a segmented numerical version of the visual analog scale (VAS). It consists of an 11-point scale where the respondent selects a whole number from 0 to 10 that best reflects the intensity of their pain, with 0 representing "no pain" and 10 representing the "worst imaginable pain" . The NPRS has demonstrated high construct and criterion validity for assessing pain severity in patients with chronic musculoskeletal disorders. It is considered a valid tool for differentiating pain characteristics between individuals with chronic neck pain and healthy controls. The research suggests that the NPRS is often more responsive to clinical changes and easier for patients to comprehend than the traditional VAS .This scale is characterized by excellent test-retest reliability (ICC: 0.95),

  • Diagnostic test3- The Neck Disability Index (Arabic version) for functional disability

    Neck disability index (NDI) is self-reported assessment includes ten items: pain severity, personal care, lifting, work, headaches, concentration, sleeping, driving, reading, and recreation. Higher scores imply a greater level of disability. Arabic version of the NDI was used to assess Arabic patients with neck pain, as the Arabic version of the NDI is reliable and valid

  • Diagnostic test4- Digital Inclinometer for Cervical Range of Motion

    A digital inclinometer is a handheld electronic device used to objectively measure the degrees of spinal curvature by detecting inclination relative to the force of gravity.In cervical spine assessment, it is used to quantify movements including flexion, extension, lateral flexion, and rotation.The digital inclinometer is recognized as a highly valid and reliable instrument for measuring cervical range of motion (CROM). Recent studies have reported excellent intra-rater and inter-rater reliability (ICC \> 0.85), particularly for cervical rotation and lateral flexion. It is often preferred over traditional goniometry because it provides precise, objective, and quantitative data that is less susceptible to manual measurement error.

  • Diagnostic test5- Arabic Tampa Scale of Kinesiophobia (TSK-11)

    The TSK-11 is a shortened, 11-item version of the original Tampa Scale, designed to assess kinesiophobia. Defined as an irrational and debilitating fear of physical movement resulting from a feeling of vulnerability to painful injury or re-injury . The Arabic version was developed to provide a linguistically and culturally adapted tool for assessing fear-avoidance beliefs in Arabic-speaking populations. The Arabic version of the TSK-11 has been cross- culturally validated and demonstrates strong psychometric properties. It exhibits high internal consistency, with Cronbach's alpha values typically ranging from 0.86 to 0.90, and excellent test-retest reliability. It shows significant concurrent validity, as scores are strongly correlated with pain intensity (NPRS) and functional disability measures like the Neck Disability Index.

  • Diagnostic test6- Overhead LASER pointer for Cervical proprioception

    An overhead LASER pointer will be used to assess cervical proprioception by performing the Cervical Joint Position Error (JPE) test. The Joint Position Sense Error (JPSE) is considered one of the essential measures to clinically assess cervical proprioception. The test has good (ICC: 0.77-0.78)

  • OtherMulligan Cervical SNAG Technique Protocol

    Patient positioning: Seated or standing, with spine in neutral or slight flexion. * Therapist hand placement: Thumb or fingers on the targeted cervical vertebra (e.g., C2-C7 or upper thoracic T1-T4). * Direction of glide: Anterior and upward glide along the plane of the facet joint, synchronized with the patient's active movement (e.g., rotation, extension) * Repetitions: 10 repetitions per session, each held for 10 seconds, with rest intervals. * Session structure: SNAG mobilizations performed first, followed by conventional exercises. * Cervical spine: Targeted for joint position sense, pain, and dizziness. Technique variations: • Minor adjustments in force direction to optimize symptom reduction.

  • OtherConventional therapy group

    Based on the American Physical Therapy Association (APTA) Clinical Practice Guidelines for Neck Pain with Mobility Deficits, participants in the conventional therapy group received a multimodal treatment program consisting of mobility exercises, strengthening and endurance training, stretching exercises, and patient education * Cervical and thoracic mobility exercises. * Strengthening and endurance exercises for the deep cervical flexors, cervical extensors, and scapulothoracic muscles. * Stretching exercises for the upper trapezius, levator scapulae, pectoral, and cervical muscles. * Patient education regarding posture, ergonomics, activity modification, and self-management strategies. Sequencing: • SNAG mobilizations performed at session start, followed by active exercises and stretching Manual therapy timing: • SNAG component adds \~10 minutes to a 20-minute exercise session

06

What researchers measure

Primary outcomes

  1. A) Postural Stability (Biodex Balance System)

    Overall Stability Index (OSI) - total amount of platform deviation. * Anterior-Posterior Stability Index (APSI) - sagittal plane sway. * Medial-Lateral Stability Index (MLSI) - frontal plane sway. These indices are mathematically defined in research: APSI and MLSI Calculated from the deviation of platform angles along X and Y axes (Higher scores = worse balance Reliability Evidence * ICC OSI = 0.92, APSI = 0.89, MLSI = 0.93 * Indicates excellent reliability for research. For chronic cervical pain with hypomobility, the most appropriate Biodex protocol (supported by evidence) is: * Static Postural Stability Test: * Platform locked * 3 trials × 20 s * Eyes open * Compute OSI, APSI, MLSI Dynamic Postural Stability Test * Platform level 8 (commonly used mid-level) * 3 trials × 20 s * Eyes open A) Compute OSI, APSI, MLSI

    Time frame: before the intervention, after 8 weeks, and at a 4-week follow- up.

Secondary outcomes

  1. Numerical Pain Rating Scale (NPRS)

    The NPRS is an 11-point self-reported scale (0-10) for pain intensity. 1. Ask the patient to rate their pain intensity on a scale from 0 = no pain to 10 = worst possible pain. 2. It can assess current pain, pain in the last 24 hours . 3. The scale is valid, reliable, and widely used in clinical and research settings. Standard instructions to participants "Please rate your pain intensity on a scale from 0 to 10, where 0 means no pain at all, and 10 means the worst pain imaginable." This standardized wording is supported by multiple trials.

    Time frame: before the intervention, after 8 weeks, and at a 4-week follow- up.

  2. Neck Disability Index (Arabic Version)

    The Arabic NDI is validated and used widely in neck pain research. * The patient completes 10 items, each scored 0-5. * Total scores range from 0-50 (or converted to %). * Disability categories: * 0-4: No disability * 5-14: Mild * 15-24: Moderate * 25-34: Severe Procedure * Provide the patient with the questionnaire. * Explain each item when needed (common in Arabic versions). * Sum the scores and classify disability.

    Time frame: before the intervention, after 8 weeks, and at a 4-week follow- up.

  3. Digital Inclinometer for Cervical ROM

    Multiple studies describe standardized inclinometer protocols Devices show good validity compared with 3D motion capture 1. Patient is usually seated upright with feet on the floor. 2. Place the inclinometer on the vertex of the head aligned with T1 or other fixed reference, depending on the device. 3. Measure flexion, extension, lateral flexion, and rotation. 4. Perform 3 trials per direction and use the mean.

    Time frame: before the intervention, after 8 weeks, and at a 4-week follow- up.

  4. Tampa Scale of Kinesiophobia (TSK-11, Arabic Version)

    Kinesiophobia was assessed using the Arabic version of the Tampa Scale of Kinesiophobia (TSK-AV-11), which is a valid and reliable tool for evaluating fear of movement in Arabic-speaking patients. It consists of 11 items scored on a 4-point Likert scale, with higher scores indicating greater fear of movement Brief and validated for chronic pain including neck pain Contains 11 items, each scored 1 (strongly disagree) to 5 (strongly agree). Procedure 1. Provide the questionnaire. 2. Ensure the patient answers all 11 items. 3. Sum all item scores (minimum 11, maximum 55). 4. Higher scores = higher kinesiophobia

    Time frame: before the intervention, after 8 weeks, and at a 4-week follow- up.

  5. Overhead Laser Pointer for Cervical Proprioception (Joint Position Error Test)

    Setup * Attach a laser pointer to the patient's forehead or headband * Place a target on the wall at a distance of 90 cm. * Align the laser to the center of the target at the neutral head position. Testing procedure 1. Patient sits upright, eyes closed (no visual feedback allowed) 2. Patient moves head: 1. Rotation right 2. Rotation left 3. Flexion 4. Extension 3. Patient returns to what they believe is the original neutral position. 4. Record the deviation in degrees from the center of the target. 5. Repeat 3-5 trials per direction; average the error

    Time frame: before the intervention, after 8 weeks, and at a 4-week follow- up.

07

Study locations

1 of 1 sites recruiting
  • Faculty of Physical Therapy Delta University
    Gamasa, Egypt
    Recruiting
    • Dr. Akram fathy abdulhamid, Assistant Professor · Principal investigator
    • Mohamed Behiry, Assistant Professor · Sub investigator
    • Mahmoud Nabhan, lecturer · Sub investigator
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2026 (actual). Primary completion is estimated for Oct 2026, 3 months after the start.

Of 768 non-industry interventional studies with no phase under Neck Pain, half reached primary completion within 7 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 15. This study's planned 3 months is below that.

Counting every sponsor, half of 777 studies reached it within 7 months; a quarter within 3 and three quarters within 15.

Start moved once since we started tracking on Sep 25, 2026: Aug 2026 → Jul 2026, on Oct 21, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jun 23, 2026
First posted
Jun 29, 2026
StartActual
Jul 20, 2026was Aug 2026
Primary completionEst.
Oct 20, 2026
CompletionEst.
Nov 1, 2026
Last update
Oct 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 21, 2026
Sites
Faculty of Physical Therapy Delta University is now Recruiting
Oct 21, 2026
Start date
Aug 20, 2026→Jul 20, 2026 (actual)
Oct 21, 2026
Show all 1 update
  1. Oct 21, 2026
    Not yet recruiting→Recruiting
    Faculty of Physical Therapy Delta University is now Recruiting
    Start date Aug 20, 2026→Jul 20, 2026 (now actual)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07673575
Lead sponsor
Menna Allah Ahmed Marei Elnaggar
Responsible party
Menna Allah Ahmed Marei Elnaggar (Demonstrator at Physical therapy for Musculoskeletal disorders and its surgeries , Faculty of Physical Therapy, Delta University, Cairo University) — Sponsor-investigator
First posted
Jun 29, 2026
Start date
Jul 20, 2026
Primary completion
Oct 20, 2026 (estimated)
Completion
Nov 1, 2026 (estimated)
Last update
Oct 21, 2026

Study contacts

Menna-Allah A Elnaggar, demonstrator
Contact
me370433@gmail.com
+201069014391
Rewan M Aloush, Teaching Assistant
Contact
rewan.aloush@gmail.com
+201024232512

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion